| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.089 | 0.07 |